News for Novo Nordisk A/S (NOVC.MU)

Generic injectable drugs are those which have same active ingredient as innovator drug and is equivalent to its innovator drug in dosage form, safety,

MARSEILLE, France, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16...

Jim Simons' Firm's Top Trades of the 4th Quarter, Stocks: ZM,BMY,CMG,ABBV,NVDA,NVO,BIDU,PDD,VRSN, Jim Simons, release date:Feb 22, 2021

Jim Simons' Firm's Top Trades of the 4th Quarter, Stocks: ZM,BMY,CMG,ABBV,NVDA,NVO,BIDU,PDD,VRSN, Jim Simons, release date:Feb 22, 2021

Newark, NJ, Feb. 18, 2021 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global pen needles market is expected to grow from USD 1.22 ...

Marseille, Feb. 17, 2021 -- Innate Pharma SA announced today that members of its senior management team are scheduled to participate in the following upcoming virtual investor conference: ... | February 17, 2021

MARSEILLE, France, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (OTC:IPHYF, NASDAQ:IPHA) ("Innate" or the "Company") announced today that members of ...

Newark, NJ, Feb. 15, 2021 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global needles market is expected to grow from USD 6.3 ...

/PRNewswire/ -- DelveInsight's Hemophilia A Market Analysis report offers an integrated view of epidemiological trends, treatment approaches, unmet needs...

Pune, India, Feb. 15, 2021 (GLOBE NEWSWIRE) -- According to the report, Digital Diabetes Management market size is projected to reach remarkable value by ...

One of the best resources for investors are the publicly available 13F-HR documents that each fund is required to submit to the SEC. These documents allow inves...

TELLOMAK trial progresses as cohort 2 of KIR3DL2-expressing mycosis fungoides patients advances to Stage 2 earlier than anticipatedCompany to init...

Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.17%

Manish Hathiramani, technical analyst at Deen Dayal Investments said, "While we have good support at 14,200-14,300, a buy on dips strategy would be most appropriate."

Denmark stocks higher at close of trade; OMX Copenhagen 20 up 1.05%

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 2) Argenx ...

MARSEILLE, France, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the ...

NIJMEGEN, Netherlands, Jan. 28, 2021 /PRNewswire/ -- To take AI development in pathology to the next level, a European consortium combining leadin...

TORONTO, Jan. 25, 2021 /CNW/ - Corporate Knights 17th annual ranking of the world's 100 most sustainable corporations is being released this morni...